INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 63 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $13,000 | -88.4% | 24,300 | -83.3% | 0.00% | -100.0% |
| Q4 2017 | $112,000 | -47.9% | 145,650 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $215,000 | -45.3% | 145,650 | 0.0% | 0.00% | -60.0% |
| Q2 2017 | $393,000 | +7.1% | 145,650 | +60.7% | 0.01% | +25.0% |
| Q1 2017 | $367,000 | -3.7% | 90,650 | 0.0% | 0.00% | -20.0% |
| Q4 2016 | $381,000 | -38.1% | 90,650 | 0.0% | 0.01% | -44.4% |
| Q3 2016 | $616,000 | +17.6% | 90,650 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $524,000 | -17.2% | 90,650 | 0.0% | 0.01% | -27.3% |
| Q1 2016 | $633,000 | – | 90,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|